[New derivatives of clofibrate and probucol. Preliminary study of their hypolipemic activity]
- PMID: 4085644
[New derivatives of clofibrate and probucol. Preliminary study of their hypolipemic activity]
Abstract
The preparation is reported of compounds with a free or esterified hydroxyisobutyric acid grouping characteristic of clofibrate, on various supporting molecules related to clofibrate itself or to probucol. Some compounds showed clear hypolipemic activity and for one compound (MG 6893) the effect was not accompanied by hepatomegalia.
Similar articles
-
Synthesis and pharmacological evaluation of a clofibrate-related tricyclic spirolactone, 5-chloro-4',5-dihydrospiro[benzofuran-2(3H),3'(2'H)-furan]-2'-one.J Med Chem. 1978 Dec;21(12):1198-202. doi: 10.1021/jm00210a005. J Med Chem. 1978. PMID: 722728
-
Effect of probucol on triton induced hyperlipidemias in CFY rats.Artery. 1985;13(2):87-94. Artery. 1985. PMID: 4084069
-
[The action of a fibric acid derivative on lipid metabolism].Rev Med Chir Soc Med Nat Iasi. 1989 Jul-Sep;93(3):573-6. Rev Med Chir Soc Med Nat Iasi. 1989. PMID: 2636755 Romanian.
-
Newer hypolipidemic compounds.Adv Exp Med Biol. 1975;63:135-50. doi: 10.1007/978-1-4684-3258-9_9. Adv Exp Med Biol. 1975. PMID: 1106139 Review. No abstract available.
-
Methods and endpoint issues in clinical development of lipid-acting agents with pleiotropic effects.Am J Cardiol. 1998 Apr 23;81(8A):17F-24F. doi: 10.1016/s0002-9149(98)00253-7. Am J Cardiol. 1998. PMID: 9604899 Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical